Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-09-19
2006-09-19
Seaman, D. Margaret (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S215000, C546S229000, C546S237000
Reexamination Certificate
active
07109342
ABSTRACT:
Piperidine derivatives represented by formula (I) or nontoxic salts thereof (wherein symbols are defined in the description):Since the compound represented by formula (I) has a PDE4 inhibitory activity, it is useful for preventing and/or treating inflammatory diseases, diabetic diseases, allergic diseases, autoimmune diseases, osteoporosis, bone fracture, obesity, depression, Parkinson's disease, dementia, ischemia-reperfusion injury, leukemia and the like.
REFERENCES:
patent: 5459151 (1995-10-01), Lombardo
patent: 5602173 (1997-02-01), Christensen, IV
patent: WO 93/19747 (1993-10-01), None
patent: WO 94/25437 (1994-11-01), None
Kishikawa Katsuya
Nakai Hisao
Ono Pharmaceutical Co. Ltd.
Seaman D. Margaret
LandOfFree
Piperidine derivatives and agent comprising the derivative... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperidine derivatives and agent comprising the derivative..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidine derivatives and agent comprising the derivative... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3581264